Mebendazole in paediatric patients with giardiasis: a systematic review and meta-analysis of randomized controlled trials
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: NMS-036
- By: ALMIRALL CARBONELL, Pedro ()
- Co-author(s): Dr Pedro Almirall Carbonell, Physician
Mebendazole (MBZ) has received attention in treating patients with giardiasis because it has shown beneficial effects both in vitro and in vivo. The aim of this study was to assess with a systematic review and meta-analysis of randomized controlled trials (RCTs) the efficacy of MBZ compared to other antigiardial agents in children. We searched.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.